Equity Analysis /
United States of America

US : Gossamer Bio, Inc. - GOSS | Maintaining Outperform; Seralutinib in PAH Still Looking Good

    Timur Ivannikov
    Timur Ivannikov

    CFA, Sr. Res. Assoc.

    Follow
    CGS-CIMB
    25 April 2022
    Published byCGS-CIMB